Skip to content

EBITDA margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
34.4%+2.7pp
Stryker logo
StrykerSYK
24.6%+4.7pp
Globus Medical logo
Globus MedicalGMED
26.3%+5.6pp
Medtronic logo
MedtronicMDT
25.9%-0.4pp
IAR
Integra LifeSciencesIART
-19.5%-30.1pp
Enovis logo
EnovisENOV
-34.1%+27.5pp

Other financials

Income statement

See full
Revenue$192.1M+13.6%
Gross profit$136.5M+17.7%
Operating income-$22.6M+49.0%
Net income-$33.9M+34.7%
EPS (diluted)-$0.22+37.1%

Balance sheet

See full
Cash & equivalents$139.9M-8.7%
Total debt$603.1M+3.7%
Total equity-$5.3M+93.8%
Total assets$799.5M+1.8%

Cash flow

See full
Operating cash flow$1.3M+126%
CapEx$12.1M+21.7%
Free cash flow-$10.8M+27.9%

Valuation

See full
Market cap$1.34B-16.3%
Enterprise value$1.8B-11.2%
P/S1.7×-0.8×

Profitability

See full
Gross margin70.2%+1.2pp
Operating margin-7.7%-3.0pp
Net margin-15.9%-4.4pp
FCF margin-12.7%-5.1pp

Returns & leverage

See full
Return on equity-812.1%
Debt / equity48×
Current ratio1.9×-0.9×

Where this comes from

Calculated from Alphatec Holdings’s reported figures.

Based on trailing twelve months.

The official record: Alphatec Holdings’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alphatec Holdings's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alphatec Holdings's EBITDA margin?
Alphatec Holdings (ATEC) reported EBITDA margin of 2.1% in Q1 2026.
How has Alphatec Holdings's EBITDA margin changed year-over-year?
Alphatec Holdings's EBITDA margin increased by 123.5% year-over-year, from -8.8% to 2.1%.
What is the long-term trend for Alphatec Holdings's EBITDA margin?
Over 5 years (2020 to 2025), Alphatec Holdings's EBITDA margin has grown at a -55.1% compound annual growth rate (CAGR), from -33.1% to -0.6%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.